Vanda Pharmaceuticals Inc. (VNDA)

Last Closing Price: 7.91 (2026-03-05)

Return on Equity (Annual)

Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity

Vanda Pharmaceuticals Inc. (VNDA) had Return on Equity of -67.38% for the most recently reported fiscal year, ending 2025-12-31.

Figures for fiscal year ending 2025-12-31
Income Statement Financials
$216.10M
$-220.47M
$13.04M
$203.06M
$367.27M
$-151.17M
$12.52M
$-138.65M
$-138.65M
$-220.47M
$-220.47M
$-220.47M
$-220.47M
$-151.17M
$-141.30M
58.93M
58.93M
$-3.74
$-3.74
Balance Sheet Financials
$347.26M
$2.25M
$141.69M
$488.95M
$145.16M
$4.08M
$16.60M
$161.76M
$327.19M
$210.10M
$327.19M
59.10M
Cash Flow Statement Financials
$-109.44M
$94.86M
$-2.91M
$102.78M
$85.32M
$-17.46M
$9.47M
--
--
Fundamental Metrics & Ratios
2.39
--
--
0.01
0.01
93.96%
-69.95%
-69.95%
-65.39%
-64.16%
-102.02%
$-110.44M
--
--
--
0.44
7.04
3.96
92.18
Return on Equity
-67.38%
-104.94%
-45.09%
-66.56%
$5.54
$-1.87
$-1.86